Investing Profile
Michelle Hasson
Your Intro Paths to Michelle Hasson
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Current Investing Position
Galen Partners Venture Partner
Investment Range
$10.0M - $30.0M
Sweet Spot
$20.0M
Current Fund Size
$1B
Michelle Hasson is on these Sector & Stage Rankings
Medical Devices (Seed)Pharmaceuticals (Seed)Consumer Health (Seed)Digital Health (Seed)Health & Hospital Services (Seed)Health IT (Seed)Medical Devices (Series A)Pharmaceuticals (Series A)Consumer Health (Series A)Digital Health (Series A)Health & Hospital Services (Series A)Health IT (Series A)Medical Devices (Series B)Pharmaceuticals (Series B)Consumer Health (Series B)Digital Health (Series B)Health IT (Series B)Health & Hospital Services (Series B)Boston / New EnglandNew York City
Michelle Hasson's Experience
Director, Board of Directors Evolve Treatment Centers2021 - Present
Board Director, Board Of Directors SMP Pharmacy Solutions, a Galen Portfolio Compamy2018 - Present
Special Venture Partner Galen Partners2015 - Present
Hospital Board and VMG Medical Group, Chair, Research committee and Member Strategy Committee Valley Hospital and Health System2014 - Present
Co Founder and CEO MitoMedical2012 - 2020
Board Director, Board of Directors, a Galen Portfolio Company Cambrooke Therapeutics (Aquired by Anjinmoto, Co., Inc.)2012 - 2017
Managing Director and Co-Founder Easton Associates, LLC (sold to Navigant Consulting in 2012)2000 - 2014
Michelle Hasson's Education
Emory University, Yale University
Investors who invest with Michelle Hasson